Evidence map›Paper›PMID 30717355›Full record

ArticleNutrients2019

Association between Sleep Disturbances and Liver Status in Obese Subjects with Nonalcoholic Fatty Liver Disease: A Comparison with Healthy Controls.

Bertha Araceli Marin-Alejandre, Itziar Abete, Irene Cantero, Jose I Riezu-Boj, Fermín I Milagro, J Ignacio Monreal, Mariana Elorz, José Ignacio Herrero, Alberto Benito-Boillos, Jorge Quiroga and 6 more

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Pharmaceutical biology · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. The Beauty Sleep to Keep a Healthy Liver.International journal of molecular sciences · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Obesity, Chronic Stress, and Stress Reduction.Gastroenterology clinics of North America · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. PPAR-PPAR research · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Bertha Araceli Marin-AlejandreDepartment of Nutrition, Food Sciences and Physiology and Centre for Nutrition Research, Faculty of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain. bmarin.1@alumni.unav.es.
Itziar AbeteDepartment of Nutrition, Food Sciences and Physiology and Centre for Nutrition Research, Faculty of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain. iabetego@unav.es.ORCID 0000-0002-6475-5387
Irene CanteroDepartment of Nutrition, Food Sciences and Physiology and Centre for Nutrition Research, Faculty of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain. icgonzalez@unav.es.
Jose I Riezu-BojDepartment of Nutrition, Food Sciences and Physiology and Centre for Nutrition Research, Faculty of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain. jiriezu@unav.es.ORCID 0000-0002-1885-8457
Fermín I MilagroDepartment of Nutrition, Food Sciences and Physiology and Centre for Nutrition Research, Faculty of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain. fmilagro@unav.es.ORCID 0000-0002-3228-9916
J Ignacio MonrealNavarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain. jimonreal@unav.es.
Mariana ElorzNavarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain. marelorz@unav.es.
José Ignacio HerreroNavarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain. iherrero@unav.es.
Alberto Benito-BoillosNavarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain. albenitob@unav.es.
Jorge QuirogaNavarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain. jquiroga@unav.es.
Ana Martinez-EcheverriaNavarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain. ana.martinez.echeverria@cfnavarra.es.
Juan Isidro Uriz-OtanoNavarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain. jurizota@cfnavarra.es.
María Pilar Huarte-MuniesaNavarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain. phuartem@cfnavarra.es.
Josep A TurBiomedical Research Centre Network in Physiopathology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, 28029 Madrid, Spain. pep.tur@uib.es.ORCID 0000-0002-6940-0761
J Alfredo MartínezDepartment of Nutrition, Food Sciences and Physiology and Centre for Nutrition Research, Faculty of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain. jalfmtz@unav.es.ORCID 0000-0001-5218-6941
M Angeles ZuletDepartment of Nutrition, Food Sciences and Physiology and Centre for Nutrition Research, Faculty of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain. mazulet@unav.es.
Navarre Institute of Health Research · ESInstituto de Salud Carlos III · ESComplejo Hospitalario de Navarra · ESUniversidad de Navarra · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The relevance of sleep patterns in the onset or evolution of nonalcoholic fatty liver disease (NAFLD) is still poorly understood. Our aim was to investigate the association between sleep characteristics and hepatic status indicators in obese people with NAFLD compared to normal weight non-NAFLD controls. Ninety-four overweight or obese patients with NAFLD and 40 non-NAFLD normal weight controls assessed by abdominal ultrasonography were enrolled. Hepatic status evaluation considered liver stiffness determined by Acoustic Radiation Force Impulse elastography (ARFI) and transaminases. Additionally, anthropometric measurements, clinical characteristics, and biochemical profiles were determined. Sleep features were evaluated using the Pittsburgh Sleep Quality Index (PSQI). Hepatic status parameters, anthropometric measurements, and clinical and biochemical markers differed significantly in NAFLD subjects compared to controls, as well as sleep efficiency, sleep disturbance score, and sleep quality score. In the NAFLD group, a higher prevalence of short sleep duration (

Indexed as

Body Mass IndexBody WeightSleepAdultBiomarkersCase-Control StudiesFemaleHardnessHumansLiverMaleMiddle AgedNon-alcoholic Fatty Liver DiseaseObesityOdds RatioOverweightBiomarkersTransaminasesNAFLDObesityPittsburgh Sleep Quality Indexsleepsleep disruptionsleep duration

Identifiers

PMID30717355
PMCPMC6412197
OpenAlexW2914292526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.